234 related articles for article (PubMed ID: 28381175)
1. Expression profile, clinical significance, and biological function of insulin-like growth factor 2 messenger RNA-binding proteins in non-small cell lung cancer.
Shi R; Yu X; Wang Y; Sun J; Sun Q; Xia W; Dong G; Wang A; Gao Z; Jiang F; Xu L
Tumour Biol; 2017 Apr; 39(4):1010428317695928. PubMed ID: 28381175
[TBL] [Abstract][Full Text] [Related]
2. The Aberrant Expression of MicroRNA-125a-5p/IGF2BP3 Axis in Advanced Gastric Cancer and Its Clinical Relevance.
Zhang J; Ding F; Jiao D; Li Q; Ma H
Technol Cancer Res Treat; 2020; 19():1533033820917332. PubMed ID: 32266868
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor formation and invasion and predicts poor prognosis in oral squamous cell carcinoma.
Lin CY; Chen ST; Jeng YM; Yeh CC; Chou HY; Deng YT; Chang CC; Kuo MY
J Oral Pathol Med; 2011 Oct; 40(9):699-705. PubMed ID: 23647076
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Impact of
Guo W; Huai Q; Wan H; Guo L; Song P; Gao S; He J
DNA Cell Biol; 2021 Feb; 40(2):316-331. PubMed ID: 33493403
[TBL] [Abstract][Full Text] [Related]
5. Increased IGF2BP3 expression promotes the aggressive phenotypes of colorectal cancer cells in vitro and vivo.
Xu W; Sheng Y; Guo Y; Huang Z; Huang Y; Wen D; Liu CY; Cui L; Yang Y; Du P
J Cell Physiol; 2019 Aug; 234(10):18466-18479. PubMed ID: 30895618
[TBL] [Abstract][Full Text] [Related]
6. STRIP2 motivates non-small cell lung cancer progression by modulating the TMBIM6 stability through IGF2BP3 dependent.
Zhang X; Chen Q; He Y; Shi Q; Yin C; Xie Y; Yu H; Bao Y; Wang X; Tang C; Dong Z
J Exp Clin Cancer Res; 2023 Jan; 42(1):19. PubMed ID: 36639675
[TBL] [Abstract][Full Text] [Related]
7. IGF2BP1 silencing inhibits proliferation and induces apoptosis of high glucose-induced non-small cell lung cancer cells by regulating Netrin-1.
Zhang J; Luo W; Chi X; Zhang L; Ren Q; Wang H; Zhang W
Arch Biochem Biophys; 2020 Oct; 693():108581. PubMed ID: 32926844
[TBL] [Abstract][Full Text] [Related]
8. Isoliquiritigenin inhibits non-small cell lung cancer progression via m
Cui Y; Wu Y; Wang C; Wang Z; Li Y; Jiang Z; Zhao W; Pan Z
Phytomedicine; 2022 Sep; 104():154299. PubMed ID: 35816995
[TBL] [Abstract][Full Text] [Related]
9. Increased KIF15 Expression Predicts a Poor Prognosis in Patients with Lung Adenocarcinoma.
Qiao Y; Chen J; Ma C; Liu Y; Li P; Wang Y; Hou L; Liu Z
Cell Physiol Biochem; 2018; 51(1):1-10. PubMed ID: 30439711
[TBL] [Abstract][Full Text] [Related]
10. IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK/STAT signalling pathway in human bladder cancer.
Huang W; Li Y; Zhang C; Zha H; Zhou X; Fu B; Guo J; Wang G
J Cell Mol Med; 2020 Dec; 24(23):13949-13960. PubMed ID: 33094561
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of polo-like kinase 1 and its clinical significance in human non-small cell lung cancer.
Wang ZX; Xue D; Liu ZL; Lu BB; Bian HB; Pan X; Yin YM
Int J Biochem Cell Biol; 2012 Jan; 44(1):200-10. PubMed ID: 22064247
[TBL] [Abstract][Full Text] [Related]
12. IGF2BP1 enhances the stability of SIK2 mRNA through m
Xu Y; Xu L; Kong Y; Li K; Li J; Xu F; Liang S; Chen B
Biochem Biophys Res Commun; 2023 Dec; 684():149113. PubMed ID: 37866243
[TBL] [Abstract][Full Text] [Related]
13. N
Zheng X; Li S; Yu J; Dai C; Yan S; Chen G; Sun C
Transl Cancer Res; 2023 Apr; 12(4):992-1005. PubMed ID: 37180667
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) promotes lung tumorigenesis via attenuating p53 stability.
Zhao W; Lu D; Liu L; Cai J; Zhou Y; Yang Y; Zhang Y; Zhang J
Oncotarget; 2017 Nov; 8(55):93672-93687. PubMed ID: 29212181
[TBL] [Abstract][Full Text] [Related]
15. RNA-binding protein KHSRP promotes tumor growth and metastasis in non-small cell lung cancer.
Yan M; Sun L; Li J; Yu H; Lin H; Yu T; Zhao F; Zhu M; Liu L; Geng Q; Kong H; Pan H; Yao M
J Exp Clin Cancer Res; 2019 Nov; 38(1):478. PubMed ID: 31775888
[TBL] [Abstract][Full Text] [Related]
16. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.
Li Z; Zhu W; Xiong L; Yu X; Chen X; Lin Q
Oncotarget; 2016 Sep; 7(38):61366-61377. PubMed ID: 27542260
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of insulin-like growth factor-II messenger RNA-binding protein 1 is associated with tumor progression in patients with lung cancer.
Kato T; Hayama S; Yamabuki T; Ishikawa N; Miyamoto M; Ito T; Tsuchiya E; Kondo S; Nakamura Y; Daigo Y
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):434-42. PubMed ID: 17255263
[TBL] [Abstract][Full Text] [Related]
19. The Oncogenic Functions of Insulin-like Growth Factor 2 mRNA-Binding Protein 3 in Human Carcinomas.
Wang PF; Wang X; Liu M; Zeng Z; Lin C; Xu W; Ma W; Wang J; Xiang Q; Johnston RN; Liu H; Liu SL
Curr Pharm Des; 2020; 26(32):3939-3954. PubMed ID: 32282295
[TBL] [Abstract][Full Text] [Related]
20. Targeting insulin-like growth factor-binding protein-3 by microRNA-125b promotes tumor invasion and poor outcomes in non-small-cell lung cancer.
Wang HH; Wang YC; Wu DW; Hung CS; Chen CY; Lee H
Tumour Biol; 2017 Apr; 39(4):1010428317694316. PubMed ID: 28378642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
